Archive for January 2026

Nasodine® Throat Spray launches in Singapore

Firebrick Pharma (ASX:FRE) is very pleased to announce that its new product – Nasodine® Throat Spray – has been launched in Singapore. This follows successful completion of commercial manufacturing in Australia in November and December 2025, and shipment to Singapore in early January 2026. Nasodine Throat Spray is a 1% povidone-iodine solution designed for oral…